Market research
ASG.V Aurora Spine Corporation
V CAD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- 3.6
- Dividend yield
- Not available
- Beta
- -0.56
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- CA05206X1087
- Market cap
- 17M
- P/E ratio
- Not available
- Analyst target
- 3.6
- Dividend yield
- Not available
- Beta
- -0.56
About
About Aurora Spine Corporation
Aurora Spine Corporation, through its subsidiary, Aurora Spine, Inc., engages in the development and distribution of minimally invasive interspinous fusion systems and devices in Canada. The company offers interspinous process lumbar fusion devices, such as the ZIP, ZIP ULTR, ZIP LP, and ZIP-51 for patients suffering from degenerative disc diseases. It also provides SOLO, an anterior lumbar interbody fusion 3D printed stand-alone lumbar fusion device, which is an integrated plate and spacer system that helps to preserve the natural anatomic profile while providing spinal column support and stability; and SiLo, a posterior allograft implant; and SiLO TFX, a titanium implant device for sacroiliac joint fusion. In addition, the company offers Dexa-C, a 3D printed cervical fusion device, which is a porous 3D-printed intervertebral cage that incorporates lattice pattern options to support the matching of patients' bone quality, as well as DEXA SOLO-L, a spinal device implanted in the intervertebral body space. Further, it provides TiNano, which offers a product line of lumbar fusion devices. It serves orthopaedic, neuromolecular, pain, and interventional radiological surgeons. The company was founded in 2013 and is headquartered in Toronto, Canada.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the ASG.V discussion.
5 years, 5 months ago
Aurora Spine Corporation is currently in a long term uptrend where the price is trading 37.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.1.
Aurora Spine Corporation's total revenue sank by 6.4% to $2M since the same quarter in the previous year.
Its net income has increased by 180.5% to $336K since the same quarter in the previous year.
Finally, its free cash flow grew by 96.4% to $183K since the same quarter in the previous year.
Based on the above factors, Aurora Spine Corporation gets an overall score of 4/5.